Ledger.Open graph →

SEC Form D · filed June 22, 2016

Alzamend Neuro, Inc

Offering

$1.0M

Sold

—

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SALT LAKE CITY, UT

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Philip Mansour · Las Vegas, NVExec · Director William B. Horne · Salt Lake City, UTExec · Director Milton C. Ault Iii · Salt Lake City, UTDirector D. K. Mcallaster, Jr · PHOENIX, AZDirector John M. Pons · PHOENIX, AZExec · Director Matthew Ogle · Eden Prairie, MNExec · Director Juan Sabater · Seattle, WAExec · Director Joseph Hanauer · Seattle, WAExec · Director Matthew Ehrlichman · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗